| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/16/1999 | US5882907 Design of new ribozymes capable of self-catalyzed trans-splicing which are based upon the catalytic core of a group i intron are described |
| 03/16/1999 | US5882651 Attenuated respiratory syncytial virus vaccine compositions |
| 03/16/1999 | CA2086831C Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| 03/11/1999 | WO1999011764A2 Methods for generating high titer helper-free preparations of recombinant aav vectors |
| 03/11/1999 | WO1999011763A2 Method for purifying and concentrating aav-2 and antigen portions thereof |
| 03/11/1999 | WO1999011762A1 An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
| 03/11/1999 | WO1999011761A1 Suspension culture of retroviral producer cells |
| 03/11/1999 | WO1998056937A3 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 03/11/1999 | WO1998044788A3 Animal model for evaluation of vaccines |
| 03/11/1999 | WO1998042847A3 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 03/11/1999 | WO1998033509A3 Useful properties of human lactoferrin and variants thereof |
| 03/11/1999 | CA2830694A1 Methods for generating high titer helper-free preparations of recombinant aav vectors |
| 03/11/1999 | CA2682108A1 Methods for generating high titer helper-free preparations of recombinant aav vectors |
| 03/10/1999 | EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 03/10/1999 | EP0900089A1 Biological material free of viral and molecular pathogens and a process for the production thereof |
| 03/10/1999 | EP0900087A1 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality |
| 03/10/1999 | EP0494158B1 A recombinant birth control vaccine |
| 03/10/1999 | CN1210558A Recombinant phages |
| 03/09/1999 | US5880103 Administering to mammal nucleic acid which expresses immunogenic peptide within cell to elicit t-cell mediated immune response |
| 03/09/1999 | US5880102 Adenoviral vector system |
| 03/09/1999 | US5879933 Mammalian Retrotransposons |
| 03/09/1999 | US5879925 Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains |
| 03/09/1999 | US5879924 Immortalized cell lines for virus growth |
| 03/09/1999 | US5879685 Antigens for influenza |
| 03/04/1999 | WO1999010537A1 A tumor suppressor designated ts10q23.3 |
| 03/04/1999 | WO1999010516A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 03/04/1999 | WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors |
| 03/04/1999 | WO1998055641A3 Somatic gene therapy to suppress secondary cataract formation |
| 03/04/1999 | WO1998055626A3 Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine |
| 03/04/1999 | DE19737442A1 Proteinumhüllte Polyribonukleinsäuren, ein Verfahren zu ihrer Herstellung und ihre Verwendung Proteinumhüllte Polyribonukleinsäuren, a process for their preparation and their use |
| 03/04/1999 | CA2302293A1 Receptor-mediated gene delivery using bacteriophage vectors |
| 03/04/1999 | CA2301199A1 A tumor suppressor designated ts10q23.3 |
| 03/02/1999 | US5877279 Materials for the production of nanometer structures and use thereof |
| 03/02/1999 | US5877005 Viral inactivation method using near critical, supercritical or critical fluids |
| 03/02/1999 | US5877004 Human cytomegalovirus containing a β-glucuronidase marker gene |
| 03/02/1999 | US5876920 Screening for vircides and viral suppressors by contacting infected cell with agent, determining if suppression of prenylation of proteins; against hepatitis virus |
| 03/02/1999 | US5876732 Envelope protein |
| 03/02/1999 | US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition |
| 03/02/1999 | US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/02/1999 | CA1340414C Inactivation of human immunodeficiency virus (hiv) in protein-containing solutions by phenols |
| 02/25/1999 | WO1999009199A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |
| 02/25/1999 | WO1999009189A1 Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained |
| 02/25/1999 | WO1999008692A1 Reovirus for the treatment of neoplasia |
| 02/25/1999 | CA2301978A1 Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained |
| 02/25/1999 | CA2301801A1 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |
| 02/24/1999 | EP0897987A2 Secretion of human protein linked to gamma interferon signal peptide |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
| 02/23/1999 | US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 02/23/1999 | US5874303 Sustainable cell line for the production of Marek's disease vaccines |
| 02/23/1999 | US5874280 Mutant comprising insertion of heterologous dna sequence in section of bhv-1 genome and inserted polyadenylation signal |
| 02/23/1999 | US5874279 Recombinant infectious bovine rhinotracheitis virus |
| 02/23/1999 | US5874089 Protecting against canine oral papillomavirus (copy) |
| 02/23/1999 | US5874087 Modified plant viruses as vectors |
| 02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
| 02/23/1999 | CA1340403C Human b lymphotropic virus (hblv) isolation and products |
| 02/18/1999 | WO1999007869A1 Live recombinant vaccine comprising inefficiently or non-replicating virus |
| 02/18/1999 | WO1999007852A1 Vaccine against fowlpox virus |
| 02/18/1999 | WO1999007834A1 Recovery of virus from cell culture using a hypertonic salt solution |
| 02/18/1999 | WO1999007394A1 Use of herpes vectors for tumor therapy |
| 02/18/1999 | CA2299628A1 Recovery of virus from cell culture using a hypertonic salt solution |
| 02/16/1999 | US5872212 Pesticidal proteins and strains |
| 02/16/1999 | US5872005 Packaging cell lines for adeno-associated viral vectors |
| 02/16/1999 | US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871982 Hybrid vectors and genes |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871744 Method for generating birnavirus from synthetic RNA transcripts |
| 02/16/1999 | US5871742 Dna codes for polypeptides with amino acid sequences |
| 02/16/1999 | US5871727 Targeted adenovirus vectors |
| 02/16/1999 | US5871726 Tissue specific and tumor growth supperssion by adenovirus comprising prostate specific antigen |
| 02/11/1999 | WO1999006582A1 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
| 02/11/1999 | WO1999006069A1 Herpes virus replication defective mutants |
| 02/11/1999 | WO1999006068A2 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | CA2493240A1 Methods for detecting or assaying virus |
| 02/11/1999 | CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | CA2298061A1 Polynucleotide compositions |
| 02/10/1999 | EP0896058A1 Novel semaphorin z and gene encoding the same |
| 02/10/1999 | EP0895535A1 Influenza virus replicated in mammalian cell culture and vaccine production |
| 02/10/1999 | EP0895534A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| 02/10/1999 | EP0597843B1 16 kDa SURFACE PROTEIN OF P. FALCIPARUM |
| 02/09/1999 | US5869701 Method of inactivation of viral and bacterial blood contaminants |
| 02/09/1999 | US5869453 Cytotoxic T-cell epitopes |
| 02/09/1999 | US5869336 Insect cell viral expression system producing calcium activated neutral protease; treatment of alzheimer's, huntington's, parkinson's, muscular dystrophy and other central nervous system disorders |
| 02/09/1999 | US5869313 Dna fragments coding for envelope and regulatory proteins of hiv-1 strains common to united states; for vaccines and detection in blood samples |
| 02/09/1999 | US5869312 Recombinant swinepox virus |
| 02/09/1999 | US5869306 Gene transfer preparation |
| 02/09/1999 | US5869305 Nucleic acid with adeno-associated virus inverted terminal repeat sequence and 20 basepair d sequence; for replication and assembly into viral particles and/or integration into host genome for gene therapy |
| 02/09/1999 | US5869287 Method of producing particles containing nucleic acid sequences in yeast |
| 02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
| 02/09/1999 | US5869230 Gene transfer into the kidney |
| 02/09/1999 | US5869036 Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
| 02/04/1999 | WO1999005527A2 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 02/04/1999 | WO1999005301A1 Gene transfer method with the use of serum-free medium |
| 02/04/1999 | WO1999005282A1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus |
| 02/04/1999 | WO1999005272A1 Use of transcription factor brn-3a |
| 02/04/1999 | WO1999004811A1 Artificial system for the production of infectious human papillomavirus |
| 02/04/1999 | DE19733364A1 Verfahren zur Klonierung eines großen Virusgenoms Method for cloning a large viral genome |
| 02/04/1999 | CA2298107A1 Use of transcription factor brn-3a |
| 02/04/1999 | CA2298103A1 Non-b, non-c, non-g hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |